NMRA
Neumora Therapeutics, Inc. · Healthcare
CFO Joshua Pinto sold $179K of Neumora Therapeutics, Inc.
Sold$178,806
$11.39Price
15,693Shares
−7%Stake
What NMRA did after the filing
- The stock from Tue, Aug 27 close, $11.56
- +23.8%
- S&P 500, same days
- +3.1%
Measured over 30 trading days, to the Oct 9 close.
Traded Tue, Aug 27. Filed Tue, Aug 27, 1:58 PM ET, during the session. Returns use the Aug 27 close and the Oct 9 close. Not investment advice.